Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001050442-25-000018
Filing Date
2025-05-15
Accepted
2025-05-15 16:36:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4829
  Complete submission text file 0001050442-25-000018.txt   6518
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-48577 | Film No.: 25954379
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 150 S. FIFTH ST SUITE 2550 MINNEAPOLIS MN 55402
Business Address 150 S 5TH ST SUITE 2550 MINNEAPOLIS MN 55402 6123174100
DISCIPLINED GROWTH INVESTORS INC /MN (Filed by) CIK: 0001050442 (see all company filings)

EIN.: 411901233 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SCHEDULE 13G